News | June 04, 2022
Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Taiyin Yang, PhD, Executive Vice President, Pharmaceutical Development and Manufacturing to Retire After 29 Years at Gilead
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
The proposed demerger is the most significant corporate change for GSK in the last 20 years
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
These and many other questions gather worldwide experts of the pharmaceutical industry at the PHARMAP 2022 which takes place in Berlin, Germany on June, 20 - 21, 2022
Subscribe To Our Newsletter & Stay Updated
